Genetic lineage tracing identifies in situ Kit-expressing cardiomyocytes

Cell Research

Volumn 26, Issue 1, 2016, Pages 119-130

  Liu, Qiaozhen ^a   Yang, Rui ^a   Huang, Xiuzhen ^a   Zhang, Hui ^a   He, Lingjuan ^a   Zhang, Libo ^a   Tian, Xueying ^a   Nie, Yu ^b   Hu, Shengshou ^b   Yan, Yan ^c   Zhang, Li ^d   Qiao, Zengyong ^e   Wang, Qing Dong ^f   Lui, Kathy O ^g   Zhou, Bin ^a,h,i  

^a UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^b FUWAI HOSPITAL   (China)

^c FUDAN UNIVERSITY   (China)

^d ZHEJIANG UNIVERSITY   (China)

^e SOUTHERN MEDICAL UNIVERSITY   (China)

^f ASTRAZENECA R AND D   (Sweden)

^g CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^h Shenzhen Fundamental Research Institutions   (China)

ⁱ SHANGHAITECH UNIVERSITY   (China)

Author keywords

c kit; cardiac stem cell; cardiomyocyte; lineage tracing

Indexed keywords

STEM CELL FACTOR RECEPTOR;

ANIMAL; C57BL MOUSE; CARDIAC MUSCLE; CARDIAC MUSCLE CELL; CELL CULTURE; CELL LINEAGE; CYTOLOGY; GENE EXPRESSION; GENETICS; HEART; HUMAN; METABOLISM; MOUSE; PHYSIOLOGY; REGENERATION; STEM CELL;

ANIMALS; CELL LINEAGE; CELLS, CULTURED; GENE EXPRESSION; HEART; HUMANS; MICE; MICE, INBRED C57BL; MYOCARDIUM; MYOCYTES, CARDIAC; PROTO-ONCOGENE PROTEINS C-KIT; REGENERATION; STEM CELLS;

EID: 84953358910     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/cr.2015.143     Document Type: Article

References (25)

1. Anversa P, Kajstura J, Rota M, Leri A. Regenerating new heart with stem cells. J Clin Invest. 2013; 123: 62-70.
2. Garbern JC, Lee RT. Cardiac stem cell therapy and the promise of heart regeneration. Cell Stem Cell. 2013; 12: 689-698.
3. Loffredo FS, Steinhauser ML, Gannon J, Lee RT. Bone marrow-derived cell therapy stimulates endogenous cardiomyocyte progenitors and promotes cardiac repair. Cell Stem Cell. 2011; 8: 389-398.
4. Chugh AR, Beache GM, Loughran JH, et al. Administration of cardiac stem cells in patients with ischemic cardiomyopathy: the SCIPIO trial: surgical aspects and interim analysis of myocardial function and viability by magnetic resonance. Circulation. 2012; 126: S54-S64.
5. Bolli R, Chugh AR, D'Amario D, et al. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet. 2011; 378: 1847-1857.
6. van Berlo JH, Molkentin JD. An emerging consensus on cardiac regeneration. Nat Med. 2014; 20: 1386-1393.
7. Ellison GM, Vicinanza C, Smith AJ, et al. Adult c-kit(pos) cardiac stem cells are necessary and sufficient for functional cardiac regeneration and repair. Cell. 2013; 154: 827-842.
8. Molkentin JD, Houser SR. Are resident c-kit+ cardiac stem cells really all that are needed to mend a broken heart? Circ Res. 2013; 113: 1037-1039.
9. van Berlo JH, Kanisicak O, Maillet M, et al. c-kit+ cells minimally contribute cardiomyocytes to the heart. Nature. 2014; 509: 337-341.
10. Nadal-Ginard B, Ellison GM, Torella D. Absence of evidence is not evidence of absence: pitfalls of cre knock-ins in the c-Kit locus. Circ Res. 2014; 115: 415-418.
11. Molkentin JD. Letter by Molkentin regarding article, "The absence of evidence is not evidence of absence: the pitfalls of Cre Knock-Ins in the c-Kit Locus". Circ Res. 2014; 115: e21-e23.
12. Torella D, Ellison GM, Nadal-Ginard B. Adult c-kitpos Cardiac Stem Cells Fulfill Koch's Postulates as Causal Agents for Cardiac Regeneration. Circ Res. 2014; 114: e24-e26.
13. Liu Q, Huang X, Zhang H, et al. c-kit(+) cells adopt vascular endothelial but not epithelial cell fates during lung maintenance and repair. Nat Med. 2015; 21: 866-868.
14. Nakayama H, Bodi I, Correll RN, et al. alpha1G-dependent T-Type Ca2+ current antagonizes cardiac hypertrophy through a NOS3-dependent mechanism in mice. J Clin Invest. 2009; 119: 3787-3796.
15. Tallini YN, Greene KS, Craven M, et al. c-kit expression identifies cardiovascular precursors in the neonatal heart. Proc Natl Acad Sci USA. 2009; 106: 1808-1813.
16. Zaruba MM, Soonpaa M, Reuter S, Field LJ. Cardiomyogenic potential of C-kit(+)-expressing cells derived from neonatal and adult mouse hearts. Circulation. 2010; 121: 1992-2000.
17. Wu SM, Fujiwara Y, Cibulsky SM, et al. Developmental origin of a bipotential myocardial and smooth muscle cell precursor in the mammalian heart. Cell. 2006; 127: 1137-1150.
18. Christoforou N, Miller RA, Hill CM, Jie CC, McCallion AS, Gearhart JD. Mouse ES cell-derived cardiac precursor cells are multipotent and facilitate identification of novel cardiac genes. J Clin Invest. 2008; 118: 894-903.
19. Jesty SA, Steffey MA, Lee FK, et al. c-kit+ precursors support postinfarction myogenesis in the neonatal, but not adult, heart. Proc Natl Acad Sci USA. 2012; 109: 13380-13385.
20. Li M, Naqvi N, Yahiro E, et al. c-kit is required for cardiomyocyte terminal differentiation. Circ Res. 2008; 102: 677-685.
21. Kubin T, Poling J, Kostin S, et al. Oncostatin m is a major mediator of cardiomyocyte dedifferentiation and remodeling. Cell Stem Cell. 2011; 9: 420-432.
22. Madisen L, Zwingman TA, Sunkin SM, et al. A robust and high-Throughput Cre reporting and characterization system for the whole mouse brain. Nat Neurosci. 2010; 13: 133-140.
23. Zhou B, Honor LB, He H, et al. Adult mouse epicardium modulates myocardial injury by secreting paracrine factors. J Clin Invest. 2011; 121: 1894-1904.
24. Tian X, Hu T, Zhang H, et al. Subepicardial endothelial cells invade the embryonic ventricle wall to form coronary arteries. Cell Res. 2013; 23: 1075-1090.
25. Liu Q, Hu T, He L, et al. Genetic targeting of sprouting angiogenesis using Apln-CreER. Nat Commun. 2015; 6: 6020.